# Intercostal Nerve Cryoablation for Postoperative Pain Management

> **NCT03972397** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 20 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DEVICE:** Intercostal Nerve Cryoablation
- **DRUG:** Bupivacaine liposomal injectable suspension
- **DRUG:** Patient-controlled analgesia (PCA)

## Key facts

- **NCT ID:** NCT03972397
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-15
- **Primary completion:** 2022-09-22
- **Final completion:** 2022-09-22
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03972397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03972397, "Intercostal Nerve Cryoablation for Postoperative Pain Management". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03972397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*